| INK Ultra Money Free |
Latest 10 SEC filings (by transaction date) for MRNA within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -5,167 | $172.73 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -7,599 | $171.72 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 ![]() | 40,000 | $0.990 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 ![]() | -40,000 | |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Indirect Ownership | Common Stock | S - Open market or private sale ![]() | -10,000 | $174.23 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -200 | $179.54 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -500 | $178.98 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -500 | $177.46 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -9,100 | $176.54 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -3,106 | $175.61 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MRNA within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -5,167 | $172.73 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -7,599 | $171.72 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 ![]() | 40,000 | $0.990 |
Aug 12/22 | Aug 10/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -500 | $174.38 |
Aug 12/22 | Aug 10/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -6,891 | $173.73 |
Aug 12/22 | Aug 10/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -10,161 | $172.90 |
Aug 12/22 | Aug 10/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -15,158 | $171.81 |
Aug 12/22 | Aug 11/22 | Bancel Stephane | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 ![]() | -40,000 | |
Aug 12/22 | Aug 10/22 | Bancel Stephane | Direct Ownership | Common Stock | S - Open market or private sale ![]() | -7,290 | $170.93 |
Aug 12/22 | Aug 10/22 | Bancel Stephane | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 ![]() | -40,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
United Therapeutics (OQ:UTHR) |
Revolution Medicines (OQ:RVMD) |
Charles River Laboratorie (N:CRL) |